ÂÜÀòÂÒÂ×

Maryam Habibian serves as the Director and Head of Medicinal Chemistry at Korro Bio, Inc. since June 2024. Prior to this role, Maryam held positions as Director of Discovery Chemistry at Verve Therapeutics from September 2022 to May 2024, and as Associate Director and Nucleic Acid Chemistry Group Lead at Nutcracker Therapeutics from August 2021 to September 2022. Maryam's experience includes serving as a Senior Scientist and Staff Scientist at Twist Bioscience where contributions were made to advanced developments and DNA data storage R&D, respectively. As a Postdoctoral Research Fellow at Stanford University under Dr. Eric Kool, research focused on post-transcriptional RNA modifications for CRISPR/Cas9 gene editing applications. Earlier academic roles included Research and Teaching Assistant positions at McGill University and Concordia University. Maryam earned a Doctor of Philosophy (PhD) in Nucleic Acid Chemistry and Biology from McGill University and a Master of Science (MSc) in Organometallic Chemistry from Concordia University.